STOCK TITAN

AMLX (NASDAQ: AMLX) insider Justin B. Klee files Rule 144 share sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Justin B. Klee has filed a Rule 144 notice to sell 15,500 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $227,617, to be sold on or about 02/02/2026 on NASDAQ.

The filing states there are 3,363,898 shares of this class outstanding. The shares to be sold were acquired via vesting of 31,667 restricted stock units from the issuer on 02/02/2026. In the prior three months, Klee sold additional common shares in three transactions totaling several thousand shares.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Justin B. Klee’s Form 144 filing for AMLX indicate?

The filing indicates Justin B. Klee plans to sell 15,500 AMLX common shares under Rule 144. The planned sale, via Morgan Stanley Smith Barney on NASDAQ, has an aggregate market value of $227,617 based on the figures disclosed.

How many AMLX shares does Justin B. Klee plan to sell and through which broker?

He plans to sell 15,500 common shares of AMLX. The transaction is listed with Morgan Stanley Smith Barney LLC, 1 New York Plaza, as the broker, with the shares to be sold on the NASDAQ exchange.

What is the stated market value of the AMLX shares in this Form 144?

The Form 144 lists an aggregate market value of $227,617 for the 15,500 AMLX common shares. This value comes directly from the securities information table describing the planned Rule 144 sale.

When were the AMLX shares in Justin B. Klee’s Form 144 acquired?

The shares were acquired on 02/02/2026 through the vesting of restricted stock units from the issuer. The table shows 31,667 common shares acquired via RSU vesting with the same 02/02/2026 date of payment marked as N/A.

How many AMLX shares are reported as outstanding in the Form 144 filing?

The securities information table reports 3,363,898 shares of this class outstanding. This figure provides a baseline for the size of the planned 15,500-share sale relative to the total common stock outstanding.

What prior AMLX share sales by Justin B. Klee are disclosed in the last three months?

The filing lists three prior common stock sales: 1,995 shares on 01/16/2026 for $27,701, 136,193 shares on 01/15/2026 for $1,849,869, and 7,715 shares on 01/06/2026 for $85,590, all under the same Cambridge, MA address.
Amylyx Pharmaceuticals

NASDAQ:AMLX

AMLX Rankings

AMLX Latest News

AMLX Latest SEC Filings

AMLX Stock Data

1.57B
91.52M
9.5%
94.68%
9.43%
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE